ASGCT News

ASGCT Holds First Joint Meeting With Brazilian Association

ASGCT Staff - December 03, 2020

Speakers addressed the scientific and infrastructural requirements for successful translation into clinical research for oncology, hemophilia, and sickle cell disease.

ASGCT held its first ever collaborative event with the Brazilian Association of Cellular and Gene Therapy (ABTCel-Gen) virtually Dec. 2. Academic researchers from Brazil and the U.S. shared their experiences in establishing clinical trials for gene therapies to assist in advancing further development within Brazil. The ASGCT Global Outreach Committee co-hosted this program as part of its objective to encourage clinical development in middle-income countries that have burgeoning regulatory frameworks and medical systems that can support gene therapy. By facilitating the development and approval of more therapies globally, such events contribute to the Society’s strategic goal to foster equitable access to gene and cell therapies in low- and middle-income countries.

Speakers addressed the scientific and infrastructural requirements for successful translation into clinical research for oncology, hemophilia, and sickle cell disease. In addition, ASGCT Board Member Maritza McIntyre, Ph.D., provided recommendations on information to include in an IND application and ways to overcome common regulatory challenges in gene therapy trials. A recording of the program is available below. The Society will continue to partner with ABTCel-Gen when ASGCT members speak on gene editing at ABTCel-Gen’s virtual annual meeting in April.

Share This Page

Related Articles

ASGCT News

Second mRNA Vaccine for COVID-19 Approved in the U.S.

Stephen J. Russell, M.D., Ph.D. - December 18, 2020
ASGCT News

Approved mRNA Vaccine for COVID-19 is a Milestone for Gene and Cell Therapy

Stephen J. Russell, M.D., Ph.D. - December 11, 2020
ASGCT News

Exploring Gene and Cell Therapies for Prostate Cancer

Eoghan J. Mulholland, Ph.D. - November 19, 2020
ASGCT News

NHLBI-Funded Programs Provide Low-Cost Services to Gene Therapy Researchers

Edith Pfister, Ph.D. - November 11, 2020